Market Overview:
The global irritable bowel syndrome treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of IBS, rising awareness about IBS and its treatment options, and growing demand for effective and safe treatments for IBS. The global irritable bowel syndrome treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into irritable bowel syndrome with constipation (IBS-C), irritable bowel syndrome with diarrhea (IBS-D), and irritable bowel syndrome with alternating constipationand diarrhea (IBS-A). On the basis of application, the market is segmented into hospitals, clinics, and homecare settings. The regional segments are North America, Latin America Europe Asia Pacific Middle East & Africa).
Product Definition:
Irritable bowel syndrome treatment is the use of medications or therapies to treat the symptoms of irritable bowel syndrome. These treatments may include laxatives, antidiarrheal drugs, and antidepressants. The importance of irritable bowel syndrome treatment is that it can help relieve the symptoms of irritable bowel syndrome.
Irritable Bowel Syndrome with Constipation:
Irritable bowel syndrome (IBS) is a collection of symptoms that occur due to abnormal functioning of the GI tract. The most common symptom is abdominal pain or discomfort. Other symptoms include changes in stool habits, such as diarrhea or constipation, and bloating.
Irritable Bowel Syndrome with Diarrhea:
Irritable bowel syndrome (IBS) is a disorder of the GI tract characterized by abdominal pain, diarrhea, and constipation. It affects up to 20% of the global population or about 10 million people in the U.S. The exact cause of IBS is unknown; however, research suggests that it may be caused by an imbalance in brain/spinal cord nervous signaling pathways resulting from factors such as infection or injury to the area along with genetic and environmental factors.
Application Insights:
Based on application, the global irritable bowel syndrome treatment market is segmented into hospitals, clinics and other healthcare facilities, and at-home care settings. Hospitals held the largest share of over 60.0% in 2017 owing to factors such as a large patient base with high prevalence of chronic diseases such as cancer and diabetes which require long term hospital stay for management. Furthermore, rising number of surgeries in a year coupled with an increase in medical emergencies are some other factors responsible for high share held by hospitals.
The at-home care settings segment is expected to grow significantly over the forecast period due to increasing awareness amongst patients about their health conditions along with growing availability of various treatments options through online videos that can be followed by customers without any professional help at all.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about IBS, availability of effective treatment methods, and presence of a large number of manufacturers in this region. In addition, increase in per capita income and rise in consumerism are some other factors responsible for regional growth.
Asia Pacific is anticipated to be the fastest-growing segment over the forecast period owing to an increase in prevalence rates coupled with rising healthcare expenditure by governments as well as private sectors across various countries such as China & Japan & India among others). Moreover, growing medical tourism industry will also boost demand for irritable bowel syndrome treatment products leading to an increased demand from across Asia Pacific region during the forecast years 2018 - 2030 (Ref: World Travel & Tourism Council (WTTC) 2016).
Growth Factors:
- Rising prevalence of irritable bowel syndrome (IBS) is expected to drive the market growth. According to a study by the World Gastroenterology Organisation (WGO), IBS affects 11% of the global population.
- Growing awareness about IBS and its treatment options is another key factor that would fuel market growth. Increasing number of people are seeking medical help for their symptoms, which in turn is propelling demand for IBS treatments.
- Technological advancements in diagnosis and treatment of IBS are also anticipated to spur market growth over the forecast period. For instance, introduction of novel drugs and therapies such as linaclotide and rifaximin has revolutionized the way this disorder is treated currently.
- . Rising incidence rates of gastrointestinal infections such as food poisoning, traveler’s diarrhea, etc., are leading to an increase in cases of irritable bowel syndrome worldwide thereby fueling demand for its treatments.. 5.. Growing geriatric population is also a major factor that would contribute towards market expansion during the forecast period as this group is more susceptible to develop various digestive problems including IBS
Scope Of The Report
Report Attributes
Report Details
Report Title
Irritable Bowel Syndrome Treatment Market Research Report
By Type
Irritable Bowel Syndrome with Constipation, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome with alternating Constipationand Diarrhea
By Application
Hospitals, Clinics, Homecare Settings
By Companies
Bausch Health, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, GlaxoSmithKline, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Irritable Bowel Syndrome Treatment Market Report Segments:
The global Irritable Bowel Syndrome Treatment market is segmented on the basis of:
Types
Irritable Bowel Syndrome with Constipation, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome with alternating Constipationand Diarrhea
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Homecare Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Sucampo Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals
- Salix Pharmaceuticals
- Ironwood Pharmaceuticals
- GlaxoSmithKline
- Allergan
Highlights of The Irritable Bowel Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Irritable Bowel Syndrome with Constipation
- Irritable Bowel Syndrome with Diarrhea
- Irritable Bowel Syndrome with alternating Constipationand Diarrhea
- By Application:
- Hospitals
- Clinics
- Homecare Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Irritable Bowel Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for irritable bowel syndrome will vary depending on the individual's symptoms and medical history. However, some common treatments for irritable bowel syndrome include:nnu2013 Taking over-the-counter medications such as ibuprofen or motrin to relieve pain and inflammationnu2013 Eating a balanced diet that includes plenty of fiber and probiotics to help regulate gut bacteria levelsnu2013 Practicing stress management techniques such as yoga or meditation to reduce anxiety and tension in the bodynu2013 Seeking out counseling or therapy if symptoms are causing significant distress
Some of the major companies in the irritable bowel syndrome treatment market are Bausch Health, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, GlaxoSmithKline, Allergan.
The irritable bowel syndrome treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Irritable Bowel Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Irritable Bowel Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Irritable Bowel Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Irritable Bowel Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Irritable Bowel Syndrome Treatment Market Size & Forecast, 2018-2028
4.5.1 Irritable Bowel Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Irritable Bowel Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Irritable Bowel Syndrome Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Irritable Bowel Syndrome Treatment Market Size Forecast by Type
5.2.1 Irritable Bowel Syndrome with Constipation
5.2.2 Irritable Bowel Syndrome with Diarrhea
5.2.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Irritable Bowel Syndrome Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Homecare Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Irritable Bowel Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Irritable Bowel Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Irritable Bowel Syndrome Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Irritable Bowel Syndrome Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Irritable Bowel Syndrome Treatment Market Size Forecast by Type
9.6.1 Irritable Bowel Syndrome with Constipation
9.6.2 Irritable Bowel Syndrome with Diarrhea
9.6.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Homecare Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Irritable Bowel Syndrome Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Irritable Bowel Syndrome Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Irritable Bowel Syndrome Treatment Market Size Forecast by Type
10.6.1 Irritable Bowel Syndrome with Constipation
10.6.2 Irritable Bowel Syndrome with Diarrhea
10.6.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Homecare Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Irritable Bowel Syndrome Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Irritable Bowel Syndrome Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Irritable Bowel Syndrome Treatment Market Size Forecast by Type
11.6.1 Irritable Bowel Syndrome with Constipation
11.6.2 Irritable Bowel Syndrome with Diarrhea
11.6.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Homecare Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Irritable Bowel Syndrome Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Irritable Bowel Syndrome Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Irritable Bowel Syndrome Treatment Market Size Forecast by Type
12.6.1 Irritable Bowel Syndrome with Constipation
12.6.2 Irritable Bowel Syndrome with Diarrhea
12.6.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Homecare Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Irritable Bowel Syndrome Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Irritable Bowel Syndrome Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Irritable Bowel Syndrome Treatment Market Size Forecast by Type
13.6.1 Irritable Bowel Syndrome with Constipation
13.6.2 Irritable Bowel Syndrome with Diarrhea
13.6.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Irritable Bowel Syndrome Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Homecare Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Irritable Bowel Syndrome Treatment Market: Competitive Dashboard
14.2 Global Irritable Bowel Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Sucampo Pharmaceuticals
14.3.3 Abbott Laboratories
14.3.4 Lexicon Pharmaceuticals
14.3.5 Salix Pharmaceuticals
14.3.6 Ironwood Pharmaceuticals
14.3.7 GlaxoSmithKline
14.3.8 Allergan
